Huapeng Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Huapeng Lu has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Xia Xin
Department of Nursing, The First Affiliated Hospital, Xi’an Jiaotong University, Xi’an, Shaanxi, P. R. China
6 shared publicationsXuemei Zheng
Department of Nursing The First Affiliated Hospital, Xi'an Jiaotong University Xi'an China
5 shared publications- Qinling Yang
Department of Hepatobiliary and Pancreas Surgery The First Affiliated Hospital, Xi'an Jiaotong University Xi'an China
4 shared publications Lan Lang
Department of Nursing, The First Affiliated Hospital, Xi’an Jiaotong University, Xi’an, Shaanxi, P. R. China
3 shared publicationsQigui Xiao
Department of Hepatobiliary and Pancreas Surgery, The First Affiliated Hospital, Xi’an Jiaotong University, Xi’an, Shaanxi, P. R. China
3 shared publicationsYali Sun
Department of Hepatobiliary and Pancreas Surgery, The First Affiliated Hospital, Xi’an Jiaotong University, Xi’an, Shaanxi, P. R. China
3 shared publications
Latest Publications
- 12 July 2026
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 27 (6) , 2637-2646
Developing a practical Hospital Intravenous Therapy Quality Assessment Tool: Design, refinement, and feasibility
Background: Intravenous therapy involves high-volume, invasive procedures that are inherently associated with patient discomfort and distress. When not managed optimally, such procedures can directly impact treatment efficacy and carry risks of severe complications. Intravenous therapy quality monitoring is essential for patient safety, yet standardized, practical tools for hospital-wide audits remain a critical gap. Objective: This study aimed to develop and refine a practical, electronic quality assessment tool for hospital-wide intravenous therapy surveillance, and to evaluate its feasibility in clinical practice. This is Phase I of a larger project; Phase II will apply the tool to identify outcome gaps and drive improvement. Methods: A multidisciplinary team developed the initial Hospital Intravenous Therapy Quality Assessment Tool (HIT-QAT) based on international and national standards. The tool underwent 14 iterative refinement cycles through hospital-wide cross-sectional surveys from June 2016 to May 2023. Each cycle involved: pilot testing, standardized auditor training, full-scale audit, data analysis, feedback sessions, and tool revision. Feasibility metrics included audit completion time, data completeness, and user acceptance. Results: The finalized HIT-QAT structure comprises seven sections: Introduction, Infusion Status Basics, Medication Usage, Vascular Access Device (VAD) Selection, VAD Insertion & Management (Butterfly devices, Peripheral intravenous catheter (PIVC), Midline catheter, CVC, PICC, PORT, Other devices), Infusion Device Usage, Instructions. HIT-QAT is an electronic, mobile-accessible survey with automated skip logic. Across 14 audits conducted from 2016 to 2023, A total of 22,789 VADs were assessed by 67–76 trained audit liaisons per cycle. All audit liaisons completed a standardized 1-h training with zero resistance. Conclusion: The HIT-QAT is a feasible, practical, and efficient electronic tool for hospital-wide intravenous therapy quality assessment. This paper reports Phase I: tool design, refinement, and feasibility testing. Future studies (Phase II) will apply the tool to systematically identify practice deficiencies, track outcomes, and evaluate quality improvement interventions.
- 12 July 2026
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 27 (6) , 2637-2646
Developing a practical Hospital Intravenous Therapy Quality Assessment Tool: Design, refinement, and feasibility
Background: Intravenous therapy involves high-volume, invasive procedures that are inherently associated with patient discomfort and distress. When not managed optimally, such procedures can directly impact treatment efficacy and carry risks of severe complications. Intravenous therapy quality monitoring is essential for patient safety, yet standardized, practical tools for hospital-wide audits remain a critical gap. Objective: This study aimed to develop and refine a practical, electronic quality assessment tool for hospital-wide intravenous therapy surveillance, and to evaluate its feasibility in clinical practice. This is Phase I of a larger project; Phase II will apply the tool to identify outcome gaps and drive improvement. Methods: A multidisciplinary team developed the initial Hospital Intravenous Therapy Quality Assessment Tool (HIT-QAT) based on international and national standards. The tool underwent 14 iterative refinement cycles through hospital-wide cross-sectional surveys from June 2016 to May 2023. Each cycle involved: pilot testing, standardized auditor training, full-scale audit, data analysis, feedback sessions, and tool revision. Feasibility metrics included audit completion time, data completeness, and user acceptance. Results: The finalized HIT-QAT structure comprises seven sections: Introduction, Infusion Status Basics, Medication Usage, Vascular Access Device (VAD) Selection, VAD Insertion & Management (Butterfly devices, Peripheral intravenous catheter (PIVC), Midline catheter, CVC, PICC, PORT, Other devices), Infusion Device Usage, Instructions. HIT-QAT is an electronic, mobile-accessible survey with automated skip logic. Across 14 audits conducted from 2016 to 2023, A total of 22,789 VADs were assessed by 67–76 trained audit liaisons per cycle. All audit liaisons completed a standardized 1-h training with zero resistance. Conclusion: The HIT-QAT is a feasible, practical, and efficient electronic tool for hospital-wide intravenous therapy quality assessment. This paper reports Phase I: tool design, refinement, and feasibility testing. Future studies (Phase II) will apply the tool to systematically identify practice deficiencies, track outcomes, and evaluate quality improvement interventions.
- Open Access
- 15 April 2024
- Published by Wiley in Nursing Open
- Vol. 11 (4) , e2144
The mediating role of resilience between emotional intelligence and academic procrastination in nursing undergraduates: A cross‐sectional study
Aim: To investigate the relationship among emotional intelligence (EI), resilience and academic procrastination (AP), and provide suggestions for the development of targeted intervention strategies and lowering of AP level of nursing undergraduates.Design: A cross‐sectional study.Methods: Three provincial universities offering nursing courses in China were investigated in this study. A convenience sample of 256 nursing undergraduates from May 2021 to September 2021 were recruited, with a response rate of 91.4%. Data were collected using face‐to‐face interviews. The survey tools included the General Information Questionnaire, Academic Procrastination Scale, Emotional Intelligence Scale and Resilience Scale. IBM SPSS v19.0 and Amos 22.0 were used for data analysis.Results: The AP of sampled nursing undergraduates was at the middle level (54.4 ± 21.5). The AP of nursing undergraduates was negatively correlated with EI and resilience. Moreover, the analysis on the mediating role of resilience via structural equation model showed a good fit, with χ2/df = 2.34, RMSEA = 0.07, CFI = 0.99, GFI = 0.95, TLI = 0.98.Patient or Public Contribution: No patient or public contribution.
- 15 April 2024
- Published by Wiley in Nursing Open
- Vol. 11 (4) , e2144
Open AccessThe mediating role of resilience between emotional intelligence and academic procrastination in nursing undergraduates: A cross‐sectional study
Aim: To investigate the relationship among emotional intelligence (EI), resilience and academic procrastination (AP), and provide suggestions for the development of targeted intervention strategies and lowering of AP level of nursing undergraduates.Design: A cross‐sectional study.Methods: Three provincial universities offering nursing courses in China were investigated in this study. A convenience sample of 256 nursing undergraduates from May 2021 to September 2021 were recruited, with a response rate of 91.4%. Data were collected using face‐to‐face interviews. The survey tools included the General Information Questionnaire, Academic Procrastination Scale, Emotional Intelligence Scale and Resilience Scale. IBM SPSS v19.0 and Amos 22.0 were used for data analysis.Results: The AP of sampled nursing undergraduates was at the middle level (54.4 ± 21.5). The AP of nursing undergraduates was negatively correlated with EI and resilience. Moreover, the analysis on the mediating role of resilience via structural equation model showed a good fit, with χ2/df = 2.34, RMSEA = 0.07, CFI = 0.99, GFI = 0.95, TLI = 0.98.Patient or Public Contribution: No patient or public contribution.
- 1 June 2021
- Published by Wiley in International Journal of Nursing Practice
- Vol. 28 (2) , e12976
A meta‐analysis of the comparison of phlebitis between midline catheters and peripherally inserted central catheters in infusion therapy
Aims: To compare the risk of phlebitis between midline catheters and peripherally inserted central catheters in infusion therapy with a meta‐analysis.Design: This was a systematic literature review and meta‐analysis.Data Sources: Web of Science, PubMed, Scopus, Embase, Cochrane Library, ProQuest, CNKI, WanFang, VIP and SinoMed were searched from inception to May 2020.Review Methods: All studies comparing the risk of phlebitis between midline catheters and peripherally inserted central catheters were included. According to the inclusion and exclusion criteria, two authors independently assessed the literature and extracted the data. Meta‐analyses were conducted to generate estimates of phlebitis risk in patients with midline catheters verse peripherally inserted central catheters, and publication bias was evaluated with RevMan 5.3.Results: A total of seven studies were collected, involving 1377 participants. The incidence of phlebitis with midline catheters and peripherally inserted central catheters was 1.52% and 3.41%. Meta‐analysis showed that the incidence of phlebitis has no significant difference between midline catheters and peripherally inserted central catheters. The sensitivity analysis shows that the results from this meta‐analysis are fair in overall studies. All studies have no significant publication bias.Conclusion: This study provides the first systematic assessment of the risk of phlebitis between midline catheters and peripherally inserted central catheters. The incidence of phlebitis has no significant difference between them. There are many factors to consider when choosing vascular access devices.
- 1 June 2021
- Published by Wiley in International Journal of Nursing Practice
- Vol. 28 (2) , e12976
A meta‐analysis of the comparison of phlebitis between midline catheters and peripherally inserted central catheters in infusion therapy
Aims: To compare the risk of phlebitis between midline catheters and peripherally inserted central catheters in infusion therapy with a meta‐analysis.Design: This was a systematic literature review and meta‐analysis.Data Sources: Web of Science, PubMed, Scopus, Embase, Cochrane Library, ProQuest, CNKI, WanFang, VIP and SinoMed were searched from inception to May 2020.Review Methods: All studies comparing the risk of phlebitis between midline catheters and peripherally inserted central catheters were included. According to the inclusion and exclusion criteria, two authors independently assessed the literature and extracted the data. Meta‐analyses were conducted to generate estimates of phlebitis risk in patients with midline catheters verse peripherally inserted central catheters, and publication bias was evaluated with RevMan 5.3.Results: A total of seven studies were collected, involving 1377 participants. The incidence of phlebitis with midline catheters and peripherally inserted central catheters was 1.52% and 3.41%. Meta‐analysis showed that the incidence of phlebitis has no significant difference between midline catheters and peripherally inserted central catheters. The sensitivity analysis shows that the results from this meta‐analysis are fair in overall studies. All studies have no significant publication bias.Conclusion: This study provides the first systematic assessment of the risk of phlebitis between midline catheters and peripherally inserted central catheters. The incidence of phlebitis has no significant difference between them. There are many factors to consider when choosing vascular access devices.
- Open Access
- 15 May 2021
- Published by Wiley in Nursing Open
- Vol. 9 (3) , 1873-1882
The risk of venous thromboembolism associated with midline catheters compared with peripherally inserted central catheters: A systematic review and meta‐analysis
Background: Both midline catheters (MCs) and peripherally inserted central catheters (PICCs) can cause venous thromboembolism (VTE), but the prevalence associated with each is controversial.Objective: To compare the risk of VTE between MCs and PICCs with a systematic review and meta‐analysis.Methods: The Web of Science Core Collection, PubMed, Scopus, Embase, the Cochrane Library and ProQuest were searched from inception to January 2020. All studies comparing the risk of VTE between MCs and PICCs were included. Selected studies were assessed for methodological quality using the Downs and Black checklist. Two authors independently assessed the literature and extracted the data. Any different opinion was resolved through third‐party consensus. Meta‐analyses were conducted to generate estimates of VTE risk in patients with MCs versus PICCs, and publication bias was evaluated with RevMan 5.3.Results: A total of 86 studies were identified. Twelve studies were recruited, involving 40,871 patients. The prevalence of VTE with MCs and PICCs was 3.97% (310/7806) and 2.29% (758/33065), respectively. Meta‐analysis showed that the prevalence of VTE with MCs was higher than that with PICCs (RR=1.53, 95% CI: 1.33–1.76, p < .00001). Subgroup analyses by age showed that the prevalence of VTE with MCs was higher than that with PICCs in the adult group (RR=1.75, 95% CI: 1.38–2.22, p < .00001), and higher than that with PICCs in the other subgroups (RR=1.42, 95% CI: 1.19–1.69, p = .0001). Subgroup analyses by nation showed that the prevalence of VTE with MCs was higher than that with PICCs (RR=1.50, 95% CI: 1.30–1.73, p < .00001) in US subgroup and higher than that with PICCs (RR=2.87, 95% CI: 1.24–6.65, p = .01) in the other nations. The sensitivity analysis shows that the results from this meta‐analysis are robust and all studies have no significant publication bias.Conclusions: This study provides the first systematic assessment of the risk of VTE between MCs and PICCs. MCs are associated with a higher risk of VTE than PICCs in all patients and adults. The findings of this study have several important implications for future practice. However, the risk of VTE between MCs and PICCs in children is unclear.
- 15 May 2021
- Published by Wiley in Nursing Open
- Vol. 9 (3) , 1873-1882
Open AccessThe risk of venous thromboembolism associated with midline catheters compared with peripherally inserted central catheters: A systematic review and meta‐analysis
Background: Both midline catheters (MCs) and peripherally inserted central catheters (PICCs) can cause venous thromboembolism (VTE), but the prevalence associated with each is controversial.Objective: To compare the risk of VTE between MCs and PICCs with a systematic review and meta‐analysis.Methods: The Web of Science Core Collection, PubMed, Scopus, Embase, the Cochrane Library and ProQuest were searched from inception to January 2020. All studies comparing the risk of VTE between MCs and PICCs were included. Selected studies were assessed for methodological quality using the Downs and Black checklist. Two authors independently assessed the literature and extracted the data. Any different opinion was resolved through third‐party consensus. Meta‐analyses were conducted to generate estimates of VTE risk in patients with MCs versus PICCs, and publication bias was evaluated with RevMan 5.3.Results: A total of 86 studies were identified. Twelve studies were recruited, involving 40,871 patients. The prevalence of VTE with MCs and PICCs was 3.97% (310/7806) and 2.29% (758/33065), respectively. Meta‐analysis showed that the prevalence of VTE with MCs was higher than that with PICCs (RR=1.53, 95% CI: 1.33–1.76, p < .00001). Subgroup analyses by age showed that the prevalence of VTE with MCs was higher than that with PICCs in the adult group (RR=1.75, 95% CI: 1.38–2.22, p < .00001), and higher than that with PICCs in the other subgroups (RR=1.42, 95% CI: 1.19–1.69, p = .0001). Subgroup analyses by nation showed that the prevalence of VTE with MCs was higher than that with PICCs (RR=1.50, 95% CI: 1.30–1.73, p < .00001) in US subgroup and higher than that with PICCs (RR=2.87, 95% CI: 1.24–6.65, p = .01) in the other nations. The sensitivity analysis shows that the results from this meta‐analysis are robust and all studies have no significant publication bias.Conclusions: This study provides the first systematic assessment of the risk of VTE between MCs and PICCs. MCs are associated with a higher risk of VTE than PICCs in all patients and adults. The findings of this study have several important implications for future practice. However, the risk of VTE between MCs and PICCs in children is unclear.
- Open Access
- 24 March 2021
- Published by Wiley in Journal of Diabetes Research
- Vol. 2021, 1-15
A Meta-Analysis of a Cohort Study on the Association between Sleep Duration and Type 2 Diabetes Mellitus
Objective. To study the association between sleep duration and the incidence of type 2 diabetes mellitus (T2DM) and to provide a theoretical basis for the prevention of T2DM through a meta-analysis. Methods. PubMed, Web of Science, Scopus, Embase, Cochrane Library, ProQuest, CNKI, Wanfang, VIP, and SINOMED were searched from their inception until May 2020. All cohort studies on the relationship between sleep duration and T2DM in adults were included. According to the inclusion and exclusion criteria, two authors independently assessed the literature and extracted the data. Metaregression and publication bias were evaluated, and sensitivity and meta-analyses were conducted with RevMan 5.3. Results. A total of 17 studies were collected, involving 737002 adults. The incidence of T2DM was 4.73% in short sleep duration (SSD) ( ), 4.39% in normal sleep duration (NSD) ( ), and 4.99% in long sleep duration (LSD) ( ). The meta-analysis demonstrated that SSD increased the risk of T2DM compared with NSD ( , 95% CI: 1.15-1.29, ), LSD increased the risk of T2DM compared with NSD ( , 95% CI: 1.15-1.39, ), and the risk of T2DM has no significant difference between SSD and LSD ( , 95% CI: 0.89-1.05, ). The sensitivity of each study was robust and the publication bias was weak. Conclusion. SSD or LSD can increase the risk of T2DM.
- 24 March 2021
- Published by Wiley in Journal of Diabetes Research
- Vol. 2021, 1-15
Open AccessA Meta-Analysis of a Cohort Study on the Association between Sleep Duration and Type 2 Diabetes Mellitus
Objective. To study the association between sleep duration and the incidence of type 2 diabetes mellitus (T2DM) and to provide a theoretical basis for the prevention of T2DM through a meta-analysis. Methods. PubMed, Web of Science, Scopus, Embase, Cochrane Library, ProQuest, CNKI, Wanfang, VIP, and SINOMED were searched from their inception until May 2020. All cohort studies on the relationship between sleep duration and T2DM in adults were included. According to the inclusion and exclusion criteria, two authors independently assessed the literature and extracted the data. Metaregression and publication bias were evaluated, and sensitivity and meta-analyses were conducted with RevMan 5.3. Results. A total of 17 studies were collected, involving 737002 adults. The incidence of T2DM was 4.73% in short sleep duration (SSD) ( ), 4.39% in normal sleep duration (NSD) ( ), and 4.99% in long sleep duration (LSD) ( ). The meta-analysis demonstrated that SSD increased the risk of T2DM compared with NSD ( , 95% CI: 1.15-1.29, ), LSD increased the risk of T2DM compared with NSD ( , 95% CI: 1.15-1.39, ), and the risk of T2DM has no significant difference between SSD and LSD ( , 95% CI: 0.89-1.05, ). The sensitivity of each study was robust and the publication bias was weak. Conclusion. SSD or LSD can increase the risk of T2DM.
- 12 March 2021
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 23 (3) , 436-442
The safety of clinically indicated replacement or routine replacement of peripheral intravenous catheters: A randomized controlled study
The primary purpose of this study was to explore the safety of peripheral intravenous catheter (PIVC) replacement every 96 h compared to that of clinically indicated catheter removal. A prospective, single-blind, randomized controlled trial was conducted. A random number table method was used. Six hundred patients treated with PIVC intravenous infusion in 10 nursing units of a hospital from September to October 2019 were selected. Sixty were collected from each nursing unit, including 30 in the clinically indicated replacement group and 30 in the routine replacement group. The incidence of phlebitis, catheter-related infection (CRI), occlusion, infiltration, and any form of infusion therapy failure were compared between the two groups. SPSS 23.0 software was used. The dwelling times of PIVC in the clinically indicated replacement group and routine replacement group were significantly different (hours) (83.62 ± 50.08, 69.75 ± 25.54, t = 3.021, p = 0.003). The incidence of any form of infusion therapy failure (RR = 4.448, 95% CI: 3.158–6.265, p < 0.001), phlebitis (RR = 2.416, 95% CI: 1.595–3.660, p < 0.001), occlusion (RR = 6.610, 95% CI: 3.062–14.268, p < 0.001), infiltration (RR = 2.607, 95% CI: 1.130–6.016, p = 0.020), accidental dislodgement (RR = 2.027, 95% CI: 1.868–2.200, p = 0.013), and pain at the insertion site (RR = 2.521, 95% CI: 1.742–3.649, p < 0.001) was higher in the clinically indicated replacement group than that in the routine replacement group. The overall survival curve of PIVC was drawn with Kaplan–Meier survival analysis. The median survival time of intravenous infusion was 59.58 h; the cumulative survival rates of 48 h, 72 h, and 96 h were 77.00%, 51.33%, and 20.33%, respectively. Replacement of PIVC every 96 h is safer than clinically indicated.
- 12 March 2021
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 23 (3) , 436-442
The safety of clinically indicated replacement or routine replacement of peripheral intravenous catheters: A randomized controlled study
The primary purpose of this study was to explore the safety of peripheral intravenous catheter (PIVC) replacement every 96 h compared to that of clinically indicated catheter removal. A prospective, single-blind, randomized controlled trial was conducted. A random number table method was used. Six hundred patients treated with PIVC intravenous infusion in 10 nursing units of a hospital from September to October 2019 were selected. Sixty were collected from each nursing unit, including 30 in the clinically indicated replacement group and 30 in the routine replacement group. The incidence of phlebitis, catheter-related infection (CRI), occlusion, infiltration, and any form of infusion therapy failure were compared between the two groups. SPSS 23.0 software was used. The dwelling times of PIVC in the clinically indicated replacement group and routine replacement group were significantly different (hours) (83.62 ± 50.08, 69.75 ± 25.54, t = 3.021, p = 0.003). The incidence of any form of infusion therapy failure (RR = 4.448, 95% CI: 3.158–6.265, p < 0.001), phlebitis (RR = 2.416, 95% CI: 1.595–3.660, p < 0.001), occlusion (RR = 6.610, 95% CI: 3.062–14.268, p < 0.001), infiltration (RR = 2.607, 95% CI: 1.130–6.016, p = 0.020), accidental dislodgement (RR = 2.027, 95% CI: 1.868–2.200, p = 0.013), and pain at the insertion site (RR = 2.521, 95% CI: 1.742–3.649, p < 0.001) was higher in the clinically indicated replacement group than that in the routine replacement group. The overall survival curve of PIVC was drawn with Kaplan–Meier survival analysis. The median survival time of intravenous infusion was 59.58 h; the cumulative survival rates of 48 h, 72 h, and 96 h were 77.00%, 51.33%, and 20.33%, respectively. Replacement of PIVC every 96 h is safer than clinically indicated.
- Open Access
- 29 December 2020
- Published by Wiley in Nursing Open
- Vol. 8 (3) , 1292-1300
Risk of catheter‐related bloodstream infection associated with midline catheters compared with peripherally inserted central catheters: A meta‐analysis
Background: Both midline catheters (MCs) and peripherally inserted central catheters (PICCs) can cause catheter‐related bloodstream infection (CRBSI), but the prevalence associated with each is not clear.Objective: To compare the risk of CRBSI between MCs and PICCs with a meta‐analysis.Methods: The Web of Science Core Collection, PubMed, Scopus, Embase, The Cochrane Library and ProQuest were searched. All studies comparing the risk of CRBSI between MCs and PICCs were included. Selected studies were assessed for methodological quality using the Downs and Black checklist. Two authors independently assessed the literature and extracted the data. A fixed effects model was used to generate estimates of CRBSI risk in patients with MCs versus PICCs. Publication bias was evaluated, and meta‐analyses were conducted with RevMan 5.3.Results: A total of 167 studies were identified. Ten studies were collected, involving 33,322 patients. The prevalence of CRBSI with MCs and PICCs was 0.58% (40/6,900) and 0.48% (127/26,422), respectively. Meta‐analysis showed that the prevalence of CRBSI was not significantly different between MCs and PICCs (RR = 0.77, 95% CI: 0.50–1.17, p = .22). While the result showed that the prevalence of CRBSI with MCs was lower than that with PICCs (RR = 0.55, 95% CI: 0.33–0.92, p = .02) after poor‐quality studies were removed. The sensitivity analysis shows that the results from this meta‐analysis are fair in overall studies and non‐poor‐quality studies. All studies have no significant publication bias.Conclusions: This study provides the first systematic assessment of the risk of CRBSI between MCs and PICCs and provides evidence for the selection of appropriate vascular access devices for intravenous infusion therapy in nursing. The prevalence of CRBSI was not significantly different between them.
- 29 December 2020
- Published by Wiley in Nursing Open
- Vol. 8 (3) , 1292-1300
Open AccessRisk of catheter‐related bloodstream infection associated with midline catheters compared with peripherally inserted central catheters: A meta‐analysis
Background: Both midline catheters (MCs) and peripherally inserted central catheters (PICCs) can cause catheter‐related bloodstream infection (CRBSI), but the prevalence associated with each is not clear.Objective: To compare the risk of CRBSI between MCs and PICCs with a meta‐analysis.Methods: The Web of Science Core Collection, PubMed, Scopus, Embase, The Cochrane Library and ProQuest were searched. All studies comparing the risk of CRBSI between MCs and PICCs were included. Selected studies were assessed for methodological quality using the Downs and Black checklist. Two authors independently assessed the literature and extracted the data. A fixed effects model was used to generate estimates of CRBSI risk in patients with MCs versus PICCs. Publication bias was evaluated, and meta‐analyses were conducted with RevMan 5.3.Results: A total of 167 studies were identified. Ten studies were collected, involving 33,322 patients. The prevalence of CRBSI with MCs and PICCs was 0.58% (40/6,900) and 0.48% (127/26,422), respectively. Meta‐analysis showed that the prevalence of CRBSI was not significantly different between MCs and PICCs (RR = 0.77, 95% CI: 0.50–1.17, p = .22). While the result showed that the prevalence of CRBSI with MCs was lower than that with PICCs (RR = 0.55, 95% CI: 0.33–0.92, p = .02) after poor‐quality studies were removed. The sensitivity analysis shows that the results from this meta‐analysis are fair in overall studies and non‐poor‐quality studies. All studies have no significant publication bias.Conclusions: This study provides the first systematic assessment of the risk of CRBSI between MCs and PICCs and provides evidence for the selection of appropriate vascular access devices for intravenous infusion therapy in nursing. The prevalence of CRBSI was not significantly different between them.
- 3 July 2020
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 22 (2) , 273-279
A study on the management of needle-stick and sharps injuries based on total quality management in a tertiary hospital in western China
Objective: Based on the concept of total quality management, the practice of managing needle-stick and sharps injuries was analyzed to improve nursing quality. Methods: Using total quality management, an improvement plan was completed. Standard operating procedures for infusion therapy and monitoring of the circulatory system were made to reduce the utilization of winged metal needles and the frequency of needle-stick injuries. From 2015 to 2018, four cross-sectional surveys were conducted on the use of winged metal needles, peripheral intravenous catheters, central venous catheters, peripherally inserted central catheters, and implantable venous access ports and the status of needle-stick and sharps injuries in our hospital during the 4 years. Results: Four cross-sectional surveys showed that the percentage of winged metal needle utilization decreased significantly from 13% to 0.5%, and that of peripheral intravenous catheters increased from 77% to 87%. Zero tolerance of winged metal needles increased from 33 to 60 nursing units, an improvement rate of 81.82%. The number of needle-stick injuries decreased from 71 to 21, a decrease of 70.42%. Needle-stick injuries occurred mainly during waste disposal (34.71%) and needle withdrawal (18.18%) and when recapping needles (9.92%). Conclusion: Based on total quality management, the implementation of zero tolerance of winged metal needles is much better. The use of winged metal needles and the incidence of needle-stick injuries are reduced. Total quality management is of great clinical value in preventing needle-stick injuries.
- 3 July 2020
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 22 (2) , 273-279
A study on the management of needle-stick and sharps injuries based on total quality management in a tertiary hospital in western China
Objective: Based on the concept of total quality management, the practice of managing needle-stick and sharps injuries was analyzed to improve nursing quality. Methods: Using total quality management, an improvement plan was completed. Standard operating procedures for infusion therapy and monitoring of the circulatory system were made to reduce the utilization of winged metal needles and the frequency of needle-stick injuries. From 2015 to 2018, four cross-sectional surveys were conducted on the use of winged metal needles, peripheral intravenous catheters, central venous catheters, peripherally inserted central catheters, and implantable venous access ports and the status of needle-stick and sharps injuries in our hospital during the 4 years. Results: Four cross-sectional surveys showed that the percentage of winged metal needle utilization decreased significantly from 13% to 0.5%, and that of peripheral intravenous catheters increased from 77% to 87%. Zero tolerance of winged metal needles increased from 33 to 60 nursing units, an improvement rate of 81.82%. The number of needle-stick injuries decreased from 71 to 21, a decrease of 70.42%. Needle-stick injuries occurred mainly during waste disposal (34.71%) and needle withdrawal (18.18%) and when recapping needles (9.92%). Conclusion: Based on total quality management, the implementation of zero tolerance of winged metal needles is much better. The use of winged metal needles and the incidence of needle-stick injuries are reduced. Total quality management is of great clinical value in preventing needle-stick injuries.